Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Mesoblast ( (MESO) ) has issued an update.
On January 15, 2026, Mesoblast Limited reported to the ASX that a total of 1,450,333 unquoted options (ASX code MSBAI), exercisable at various prices and expiring on various dates, ceased during late 2025, primarily due to the lapse of conditional rights that could no longer be satisfied and the expiry of options without exercise on November 29, 2025 and December 19, 2025. Following these cessations, Mesoblast’s issued capital now comprises 1,290,302,187 ordinary fully paid shares on issue and a reduced pool of 79,812,236 remaining unquoted MSBAI options, alongside multiple series of unquoted warrants, signalling a modest simplification and tightening of its equity incentive and derivative securities overhang without any consideration paid for the lapsed instruments.
The most recent analyst rating on (MESO) stock is a Hold with a $21.50 price target. To see the full list of analyst forecasts on Mesoblast stock, see the MESO Stock Forecast page.
Spark’s Take on MESO Stock
According to Spark, TipRanks’ AI Analyst, MESO is a Neutral.
Mesoblast’s overall stock score reflects a company with strong growth potential but significant financial challenges. The earnings call provided positive insights into market access and product launches, which are promising for future growth. However, financial performance and valuation concerns weigh down the score, with technical indicators suggesting caution due to overbought conditions.
To see Spark’s full report on MESO stock, click here.
More about Mesoblast
Mesoblast Limited is an Australia-incorporated biotechnology company listed on the Australian Securities Exchange under the code MSB, focused on developing and commercializing advanced cellular medicines. The company’s capital structure includes a large base of ordinary fully paid shares and various classes of unquoted options and warrants that support its funding and incentive arrangements in global capital markets.
Average Trading Volume: 211,856
Technical Sentiment Signal: Strong Buy
Current Market Cap: $2.31B
For an in-depth examination of MESO stock, go to TipRanks’ Overview page.